Welcome to medications.com

Westaim Q4 Loss Widens - Quick Facts [WED.TO] - RTT News

The approval of Wellbutrin XL in seasonal major depressive illness represents Biovail's third Notice of Compliance in the past six months. ...

Posted: Fri Feb 15 13:36:00 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com